In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix–like topography  by Ishii, Osamu et al.
Evolving Technology Ishii et al
ETIn vitro tissue engineering of a cardiac graft using a
degradable scaffold with an extracellular matrix–like
topography
Osamu Ishii, MD,a,b Michael Shin, PhD,a Taijiro Sueda, MD, PhD,b and Joseph P. Vacanti, MDaFrom the Department of Surgery, Massa-
chusetts General Hospital and Harvard
Medical School,a Boston, Mass, and the
First Department of Surgery, Hiroshima
University School of Medicine,b Hiro-
shima, Japan.
Supported by a grant from the Center for
the Integration of Medicine and Innovative
Technology (CIMIT).
Received for publication Feb 8, 2005; revi-
sions received May 9, 2005; accepted for
publication May 18, 2005.
Address for reprints: Michael Shin, PhD,
Department of Surgery, Massachusetts
General Hospital and Harvard Medical
School, Boston, MA 02114 (E-mail:
michael.shin@gmail.com).
J Thorac Cardiovasc Surg 2005;130:1358-63
0022-5223/$30.00
Copyright © 2005 by The American Asso-
ciation for Thoracic Surgery
Top, Drs Ishii and Shin
Bottom, Drs Sueda and Vacantidoi:10.1016/j.jtcvs.2005.05.048
1358 The Journal of Thoracic and CardObjective: Cardiac tissue engineering has been proposed as a treatment to repair
impaired hearts. Bioengineered cardiac grafts are created by combining autologous
cell transplantation with a degradable scaffold as a temporary extracellular matrix.
Here we present a system for engineered myocardium combining cultured cardio-
myocytes and a novel biodegradable scaffold with a unique extracellular matrix–like
topography.
Methods: Cardiomyocytes were harvested from neonatal rats and cultured in vitro
on biodegradable electrospun nanofibrous poly(-caprolactone) meshes. Between
days 5 and 7, the meshes were overlaid to construct 3-dimensional cardiac grafts. On
day 14 of in vitro culture, the engineered cardiac grafts were analyzed by means of
histology, immunohistochemistry, and scanning electron microscopy.
Results: The cultured cardiomyocytes attached well to the meshes, and strong
beating was observed throughout the experimental period. The average fiber diam-
eter of the scaffold is about 250 nm, well below the size of an individual cardio-
myocyte. Hence the number of cell-cell contacts is maximized. Constructs with up
to 5 layers could be formed without any incidence of core ischemia. The individual
layers adhered intimately. Morphologic and electrical communication between the
layers was established, as verified by means of histology and immunohistochemis-
try. Synchronized beating was also observed.
Conclusions: This report demonstrates the formation of thick cardiac grafts in vitro
and the versatility of biodegradable electrospun meshes for cardiac tissue engineer-
ing. It is envisioned that cardiac grafts with clinically relevant dimensions can be
created by using this approach and combining it with new technologies to induce
vascularization.
Heart failure is one of the leading causes of morbidity and mortality inindustrialized nations. Because of the limited ability of the heart to repairitself, surgical intervention is frequently required to treat patients with
severe cardiac problems. Although treatments for both structural and functional
problems have become highly advanced, whole organ replacement remains the only
option when more conservative approaches fail. Since the 1960s, heart transplan-
tation has become the preferred treatment for patients with chronic, irreversible
heart failure, but limited donor organ supply and organ rejection remain critical
problems.1
The concept of tissue engineering was developed to alleviate the shortage of
donor organs. The objective of tissue engineering is to develop laboratory-grown
tissue or organs to replace or support the function of defective or injured body
parts.2 Tissue engineering is an interdisciplinary approach that relies on the synergy
of cell biology, materials engineering, and reconstructive surgery to achieve its goal.
One key approach in tissue engineering is the combined transplantation of cells and
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guide tissue regeneration. The fundamental hypothesis un-
derlying tissue engineering is that dissociated healthy cells
will reorganize into functional tissue when given the proper
structural support and signals. Given the appeal of this
concept, it was anticipated that cardiovascular tissue engi-
neering would become the treatment of the next generation.
However, this potential has not been fulfilled yet because of
several important considerations. Tissue engineering of a
complete heart remains a dream of the future, but substantial
progress has been made toward the development of individ-
ual components. Initial research in cardiovascular tissue
engineering focused primarily on blood vessels and heart
valves.3,4
Recently, attention has shifted to the myocardium, and
several groups have reported encouraging results in the
tissue engineering of functional heart grafts. Several groups
have relied on 3-dimensional (3-D) scaffolds to create car-
diac grafts. However, if the scaffold is too stiff, it can
interfere with the contractile motion of the cardiomyocytes.
Therefore it is imperative to choose a material with appro-
priate mechanical properties.
To this end, several materials have been assessed. Li and
associates5-7 produced 3-D contractile cardiac grafts using
gelatin sponges and synthetic biodegradable polymers. Leor
and colleagues8 reported the formation of bioengineered
cardiac grafts with 3-D alginate scaffolds. Other groups
have studied the use of extracellular matrix (ECM) scaf-
folds. Eschenhagen and coworkers9 engineered 3-D heart
tissue by gelling a mixture of cardiomyocytes and collagen.
The engineered heart tissue survived and matured after
implantation on uninjured hearts.10 Shimizu and col-
leagues11 have developed a novel approach of culturing cell
sheets without scaffolds using a temperature-responsive
polymer. Several cell sheets were layered on top of each
other to create thicker grafts.12,13 These ECM scaffolds
provide several options for obtaining functional cardiac
tissue.
As an alternative approach, we have developed an in
vitro system for creating sheets of cardiomyocytes on a
mesh consisting of ultrafine fibers.14 Our device consists of
a thin, highly porous, nonwoven fibrous mesh stretched
across a wire ring. Ultrafine polymer nanofibers were pro-
duced by means of electrostatic fiber spinning and collected
on wire rings in the form of a nonwoven mesh. Because of
the small fiber diameters, the mesh has a high specific
surface area and porosity that are beneficial for cell attach-
ment and proliferation.15-17 In our previous study cardio-
myocytes from neonatal Lewis rats were cultured on thin
electrospun poly(-caprolactone) meshes (PCL meshes). It
was found that the meshes were sufficiently flexible and did
not impede the myocyte contractions. Furthermore, this
novel scaffold can be fabricated in specific shapes and is
The Journal of Thoraciceasy to handle. Our results demonstrate that these cell-
polymer constructs can be cultured over extended periods
on thin PCL meshes in vitro. However, thicker grafts are
required to obtain sufficient function. It is hypothesized that
a clinically relevant cardiac graft will require a vasculature
to provide sufficient perfusion of oxygenated blood. As an
intermediate step toward a thick, vascularized cardiac graft,
it is important to assess the ability to increasing the thick-
ness without a vasculature and determine the maximum
thickness before core ischemia is observed in the graft.
Here we report the extension of our concept and the
development of a multilayer system as an intermediate step
toward functional cardiac grafts. Individual grafts were
stacked on top of each other, resulting in a multilayered
graft. The layered grafts were cultured for 2 weeks in vitro
and characterized by means of histology, immunohisto-
chemistry, and scanning electron microscopy.
Materials and Methods
Scaffolds
The detailed scaffold fabrication procedure is described else-
where.14 Briefly, scaffolds were made by using the electrospinning
process. A 10 wt.% stock solution was prepared by dissolving PCL
(molecular weight, 80 kDa; Aldrich, Milwaukee, Wis) in a 1:1
mixture of chloroform and methanol (Sigma, St Louis, Mo). The
polymer solution was delivered at a constant flow rate (0.1 mL/
min) to a metal tube (inner diameter, 1 mm; Cole-Parmer, Vernon
Hills, Ill) connected to a high-voltage power supply (Gamma High
Voltage Research, Ormond Beach, Fla). On applying a voltage of
12 kV, the fiber-spinning process commenced, and solid fibers
were collected in the form of nonwoven mesh on nickel-chrome
wire rings (ring diameter, 15 mm; wire thickness, 0.08 mm;
McMaster-Carr, Atlanta, Ga). A gross view of the scaffold is
shown in Figure 1, A. The thickness of an individual scaffold is 10
m. The surface topography is shown in Figure 1, B. The scaffold
Figure 1. A, Gross view of single-layer scaffold. A thin, nonwoven
fibrous mesh is suspended across a wire ring with a diameter of
about 15 mm. The thickness of the mesh is about 10 m. The wire
ring acts as a passive load to condition cardiomyocytes during in
vitro culture. B, Scanning electron microscopic micrograph of
scaffold. The electrospun fibers have an average diameter of 250
nm. The pores are interconnected and are much larger than the
fibers. The topography of the nonwoven mesh resembles that of
an extracellular matrix and facilitates cell attachment.consists of a 3-D mesh of ultrafine fibers with an ECM-like
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although occasional outliers are observed. The average fiber di-
ameter is 250 nm. The scaffolds were stored in a dessicator. Before
cell seeding, the scaffolds were placed in 70% ethanol overnight
and then immersed in a purified collagen solution (Cohesion
Technologies, Palo Alto, Calif).
Cell Source and Seeding
Primary cultures of cardiomyocytes were prepared according to
previously published procedures.14 Ventricles obtained from
3-day-old Lewis rats (Charles River Laboratories, Wilmington,
Mass) were minced into small segments (1 mm3) and enzymat-
ically digested for 10 minutes in a 37°C water bath with 0.25%
trypsin (Gibco, Grand Island, NY) and 90 U/mL collagenase 2
(Worthington, Lakewood, NJ). The dissociated cells were plated
on a Petri dish for 20 minutes at 37°C in culture medium. The
culture medium consisted of 40% M-199 medium (Gibco), 54%
Earle’s Balanced Salt Solution (Sigma), and 6% fetal bovine serum
(Gibco) supplemented with 100 U/mL penicillin and streptomycin
(Gibco). Nonadherent cells were removed and counted with a cell
counter. The cells were seeded on the scaffolds at a concentration
of 4 to 5 million cells per scaffold and incubated at 37°C in a
humidified atmosphere with 5% CO2. Cell viability was assessed
daily by means of light microscopy and videomicroscopy. In
addition, culture medium was exchanged daily for the duration of
the experiment.
Manipulation of Individual Grafts Into Multilayered
Grafts
After culturing for 5 to 7 days, layering of the individual grafts was
performed. The grafts were gently placed on top of each other. The
culture medium was gently removed and the layered constructs
were incubated for 2 hours at 37°C to improve interlayer attach-
ment. Culture medium was slowly added thereafter. In this study
up to 5 grafts were stacked on top of each other. The multilayer
grafts were cultured under the same conditions as the single-layer
grafts for 14 days from harvest. Single-layer grafts were also
cultured as controls.
Histologic and Immunohistochemical Examinations
The cross-sections of the grafts were analyzed after 14 days of in
vitro culture. After fixation with 4% paraformaldehyde, the grafts
were embedded in paraffin. Plane sections and cross-sections (5
m) were cut and stained with hematoxylin and eosin (H&E) for
general assessment. For cell F-actin staining, the grafts were
stained with a 1:20 dilution of rhodamine-conjugated phalloidin
(Sigma) for 2 hours and counterstained with 2 g/mL 4=,6=-
diamidino-2-phenylindole hydrochloride (DAPI; Sigma) for 2
minutes. Masson trichrome staining (Sigma) was also performed
for collagen assessment.
Immunohistochemical staining for cardiac troponin I was per-
formed on graft cross-sections. Sections were incubated overnight
with a 1:100 dilution of anti-cardiac troponin I antibody (Spectral
Diagnostics, Whitestone, Va), followed by a 1:200 dilution of
biotin-conjugated anti-mouse IgG antibody (DAKO, Glostrup,
Denmark) for 2 hours. The specimens were then incubated with
avidin-biotin complex reagent and 3,3=-diaminobenzidine (Sigma).
Staining for type I and II collagen was performed in an analogous
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(Accurate Chemical & Scientific Corporation, Westbury, NY). To
examine the presence of gap junctions, frozen sections were pre-
pared after acetone fixation, followed by incubation with a 1:100
dilution of anti-connexin43 antibody (Chemicon, Temecula, Calif)
overnight. Then specimens were incubated with a 1:200 diluted
fluorescein isothiocyanate–labeled anti-mouse IgG antibody. Im-
ages were obtained with a digital camera in a Nikon fluorescence
microscope.
Scanning Electron Microscopy
The fixed grafts were rinsed in 0.1 mol/L phosphate-buffered
saline (Gibco) and dehydrated in increasing concentrations of
ethanol. Dehydrated grafts were immersed in hexamethyldisi-
lazane (Fluka Chemical Corp, Milwaukee, Wis) for 15 minutes
and dried overnight in a dessicator. After drying, the samples were
mounted on aluminum stubs, sputter coated with gold-palladium,
and viewed in a scanning electron microscope (Philips XL-20;
FEI, Hillsboro, Ore) with an accelerating voltage of 10 to 20 kV.
Results
The neonatal rat cardiomyocytes attached well on the elec-
trospun PCL scaffolds. On day 3, the cardiomyocytes
started to contract. Between days 5 and 7, individual grafts
were layered on top of each other and cultured as a multi-
layered graft until day 14. Initially, weak and unsynchro-
nized contractions were observed, but as time progressed,
the contractions became stronger and more synchronized.
Figure 2, A and B, shows a comparison of the cross-sections
of a monolayer and 5-layer graft, respectively. H&E stain-
ing revealed that the individual layers are connected. Fur-
thermore, stratified cardiac tissue between connective tissue
was observed as indicated by means of Masson trichrome
staining. This is shown in Figure 2, C and D. Figure 3 shows
a planar view of the 5-layered graft by means of H&E and
Masson trichrome staining, respectively.
Sections were stained with cardiac-specific troponin I to
verify the cell phenotype. As Figure 4, A, shows, cells in the
graft stain positively for cardiac troponin I. Several cardiac
layers are shown to adhere intimately and appear to have
become homogeneous tissue. Staining for collagen demon-
strated that the ECM consisted mainly of collagen type I
(Figure 4, B). The scaffold is difficult to detect because of
the small fiber diameters. Immunofluorescent images with
anti-connexin43 antibody demonstrated diffuse formation
of gap junctions in the layered grafts. The nuclei were
counterstained with DAPI (Sigma; Figure 4, C).
Scanning electron microscopic analysis of the surface
shows an abundant coverage with several cell layers (Figure
5, A). A cross-sectional view reveals that cells have pene-
trated the entire thickness of the scaffold, although the cell
density is slightly higher on the surfaces. After 2 weeks,
nondegraded PCL fibers remain, and these can also be seen
(Figure 5, B).
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Ishii et al Evolving TechnologyFigure 2. A, Cross-sectional view of a single graft. Hematoxylin and eosin staining shows that cells have attached
to the scaffold and proliferate well through the entire thickness of the scaffold. (Original magnification 400.) B,
Cross-sectional view of a 5-layer graft. Cardiomyocytes were first cultured on individual scaffolds to induce cell
attachment. After 5 to 7 days, 5 scaffolds were gently placed on top of each other and maintained in culture. The
5-layer construct has the appearance of a single tissue segment, as shown here with hematoxylin and eosin
staining. There is no evidence of physical gaps, and it appears the individual layers have fused well. (Original
magnification 400.) C, Cross-sectional view of a single graft. Masson trichrome staining reveals the presence of
muscle and collagen throughout the entire specimen. (Original magnification 400.) D, Cross-sectional view of a
5-layer graft. Masson trichrome staining reveals the presence of collagen. In addition, a stratified cardiac
muscle–like structure can be seen. (Original magnification 400.)ETFigure 3. A, Surface view of a 5-layer graft visualized with hematoxylin and eosin staining. Cells are spread across
the entire surface. The appearance of overlapping nuclei is attributed to cells adhering to pores in the scaffold
below the surface. (Original magnification 200.) B, Surface view of a 5-layer graft visualized with Masson
trichrome staining. Cardiac muscle–like structures can be seen. (Original magnification 200.)Figure 4. A, Immunohistochemical staining for cardiac troponin I in a 5-layered graft. Cardiac troponin I–positive
cells are seen throughout the entire cross-section of the graft. (Original magnification 400.) B, Immunohisto-
chemical staining for collagen type I in a 5-layered graft. Collagen is abundantly present throughout the entire
specimen. (Original magnification 400.) C, Immunohistochemical staining for connexin43 in a 5-layered graft.
Diffuse gap junctions between the cells on 5-layered grafts can be seen. The nuclei have been counterstained with
4=,6=-diamidino-2-phenylindole hydrochloride. (Original magnification 400.)
The Journal of Thoracic and Cardiovascular Surgery ● Volume 130, Number 5 1361
Evolving Technology Ishii et al
ETDiscussion
Primary neonatal rat cardiomyocytes were cultured on novel
polymer meshes and successfully layered into multilayer
grafts. The individual layers formed homogenous tissue,
and cardiac tissue–like structures, such as sarcomeres and
gap junctions, were observed. Five-layer grafts contracted
macroscopically in a synchronized manner in vitro during
the entire experimental period.
One key requirement for clinically relevant cardiac grafts
is sufficient function immediately after implantation. This
requirement translates into a need for a high concentration
of cardiac muscle cells. This report outlines a novel ap-
proach toward myocardial grafts. The approach taken here
is based on our recently developed concept. An individual
graft approximates a monolayered cardiac muscle cell sheet
Figure 5. A, Scanning electron microscopic micrograph of a
5-layer graft. The surface is densely covered with cells after 2
weeks of culture. Scale bar  20 m. B, Scanning electron
microscopic micrograph of a 5-layer graft. The cells have pene-
trated the entire cross-section of the specimen. Nondegraded
fibers of the scaffold are also present. Scale bar  10 m.and can be used as an independent system for cardiac cell
1362 The Journal of Thoracic and Cardiovascular Surgery ● Novculture. However, because of its limited thickness (10
m), it appears unlikely that it will provide sufficient func-
tion when used alone to cover an infarcted area. Here we
demonstrate the ability of these grafts to form a building
block for clinically relevant cardiac grafts by forming mul-
tilayered structures. The grafts can be stacked to obtain
thicker grafts, and they fuse well with each other. The
presence of connexin43 indicates that the cells are rebuild-
ing gap junctions, and synchronized contractions in multi-
layered grafts are observed. The construct thickness can be
regulated by the number of layers. The use of the scaffold
also allows control over the 2-dimensional shape and size.
Because of its ECM-like topography, the nanofibrous mesh
provides sufficient surface area for cell attachment. Because
the fiber diameters are at least one order of magnitude
smaller than the cells, the number of cell-cell contacts is
maximized, thereby allowing the formation of electrical and
morphologic connections. Implant studies are currently un-
derway to further assess the clinical potential of our multi-
layered cardiac graft system.
However, because cardiac muscle cells have high meta-
bolic requirements, it is anticipated that a cardiac graft with
clinically relevant dimensions will also require a feeder
vasculature to provide sufficient nutrients and oxygen. Pre-
vious cardiac tissue-engineering studies have noted that the
cell density is highest around the periphery of the grafts,
whereas the interior had either necrotic or no cells because
of insufficient oxygen perfusion if the thickness of the graft
exceeded 100 m.18 To this end, experiments are currently
under way to combine our layered approach with endothe-
lial cell layers to arrive at a thick graft. Another approach is
to incorporate a preformed vasculature that is currently
under development in out laboratory.19 A simple network of
endothelialized channels with an inlet and outlet would also
be of interest for the clinician because the inlet and outlet
could be anastomosed to the native coronary vessels of the
recipient heart.
Cell sourcing remains a critical issue for cell transplan-
tation. Because cardiomyocytes are terminally differenti-
ated cells, they do not divide significantly, and it is difficult
to obtain autologous cardiomyocytes for transplantation.
Various cell types have recently been assessed for trans-
plantation into myocardial tissues, including myoblasts and
multipotent endothelial cells.20,21 Furthermore, stem cell
studies indicate the possibility of obtaining cardiomyocytes
from various stem cells.22 Autologous cells, in particular
multipotent cells derived from the bone marrow, might be a
desirable cell source. Important pioneering tissue-engineering
studies have recently been reported by Shin’oka’s group.23-25
In conclusion, electrospun scaffolds have been shown to be
very useful for fabricating 3-D cardiac grafts in vitro. Although
the current scaffolds provide an ECM-like topography, aspects
of the unique geometry and sheet-like microstructure of the
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yet. Our experiments (data not shown) indicate that electro-
spun nanofibers can be aligned to improve their orientation, but
the effect on cell organization remains to be seen. Although
clinical applications of cardiac tissue engineering are still far
away, autologous cardiac grafts have potential as an in vitro
heart tissue model and, depending on progress in the develop-
ment of new techniques to create blood vessels and the dis-
covery of an appropriate cell source, as improved cardiac graft
materials in clinical tissue repair.
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